406 related articles for article (PubMed ID: 25362194)
1. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function.
Boltjes A; van Montfoort N; Biesta PJ; Op den Brouw ML; Kwekkeboom J; van der Laan LJ; Janssen HL; Boonstra A; Woltman AM
J Infect Dis; 2015 Apr; 211(8):1268-78. PubMed ID: 25362194
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
[TBL] [Abstract][Full Text] [Related]
3. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
[TBL] [Abstract][Full Text] [Related]
4. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen.
Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF
J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958
[TBL] [Abstract][Full Text] [Related]
7. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.
Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ
Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451
[TBL] [Abstract][Full Text] [Related]
8. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
Chen Y; Wei H; Sun R; Tian Z
Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
[TBL] [Abstract][Full Text] [Related]
9. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.
Li M; Sun R; Xu L; Yin W; Chen Y; Zheng X; Lian Z; Wei H; Tian Z
J Immunol; 2015 Oct; 195(7):3100-9. PubMed ID: 26304988
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
[TBL] [Abstract][Full Text] [Related]
12. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells.
Shi CC; Tjwa ET; Biesta PJ; Boonstra A; Xie Q; Janssen HL; Woltman AM
J Viral Hepat; 2012 Feb; 19(2):e26-33. PubMed ID: 22239523
[TBL] [Abstract][Full Text] [Related]
15. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.
Tjwa ET; van Oord GW; Hegmans JP; Janssen HL; Woltman AM
J Hepatol; 2011 Feb; 54(2):209-18. PubMed ID: 21095036
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B.
Akbar SM; Furukawa S; Horiike N; Abe M; Hiasa Y; Onji M
J Viral Hepat; 2011 Jun; 18(6):408-14. PubMed ID: 20487261
[TBL] [Abstract][Full Text] [Related]
18. A clinical study of HBsAg-activated dendritic cells and cytokine-induced killer cells during the treatment for chronic hepatitis B.
Ma YJ; He M; Han JA; Yang L; Ji XY
Scand J Immunol; 2013 Oct; 78(4):387-93. PubMed ID: 23841728
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]